Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Le Chesnay-Rocquencourt, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of MK-8527 taken once monthly compared to emtricitabine/tenofovir taken daily for HIV-1 prevention
FranceStudy of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)
FranceStudy of intra-articular liraglutide (4P004) for patients with knee synovitis and osteoarthritis
FranceStudy of vicadrostat and empagliflozin given together or separately in people with chronic kidney disease to test safety and effectiveness
FranceStudy of DCC-3084 alone and with other cancer drugs in patients with advanced solid tumors driven by the MAPK pathway
FranceStudy of ruxolitinib cream for treating hidradenitis suppurativa in adult patients
FranceStudy of ABBV-CLS-628 to evaluate safety and effectiveness in adults with Autosomal Dominant Polycystic Kidney Disease
FranceStudy of ifinatamab deruxtecan alone or in combination with other treatments for patients with metastatic castration-resistant prostate cancer
FranceStudy of pelacarsen and inclisiran in patients with atherosclerotic cardiovascular disease who have high levels of LDL cholesterol and lipoprotein(a)
FranceEvaluation of COM701 as Maintenance Therapy for Patients with Relapsed Platinum-Sensitive Ovarian Cancer
FranceStudy on the Effects of Tebapivat and AG-946 in Patients with Sickle Cell Disease
FranceComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on acute myocardial infarction pain management and innovative treatments for severe asthma. Research includes evaluation of novel pain-relief methods and assessment of treatment discontinuation strategies.
Studies also examine beta-blocker discontinuation in patients with recovered heart function.
Extensive research in blood cancers, including multiple myeloma, acute myeloid leukemia, and various lymphomas. Studies evaluate novel drug combinations and treatment strategies.
Investigations include targeted therapies and personalized treatment approaches for various cancer types.
Research focusing on respiratory syncytial virus (RSV) prevention in infants and children. Studies evaluate new protective treatments and their safety profiles.
Trials include assessment of novel medications for preventing severe respiratory infections in vulnerable populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
